Bourse Nationale de Recherche Canada 2021
Biocodex Microbiota Foundation lance un appel à propositions au Canada pour financer une étude sur le rôle joué par le microbiome dans la santé et les maladies
July 28, 2021 10:39 ET | Biocodex Canada
MONTRÉAL, 28 juill. 2021 (GLOBE NEWSWIRE) -- Biocodex Microbiota Foundation, organisme fondé par Biocodex et dédié à soutenir des projets scientifiques inspirants qui explorent le microbiome, lance un...
Summit logo.png
Summit Therapeutics to Present Breakthrough Research Updates at the 31st Annual ECCMID Conference, including a Top-Rated ePoster
July 01, 2021 08:00 ET | Summit Therapeutics Inc.
Cambridge, MA, July 01, 2021 (GLOBE NEWSWIRE) -- Summit Therapeutics Inc. (NASDAQ: SMMT) (the “Company”) today announced that members of our scientific team will present breakthrough research...
thumbnail_Pan-Biome-logo.png
Pan-Biome Pharmaceuticals, Inc reports positive results in preclinical trial of Inflammatory Bowel Disease: oral drug shows strong effect in modulating the gut microbiome
February 24, 2021 10:00 ET | Pan-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 24, 2021 (GLOBE NEWSWIRE) -- Pan-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on chronic inflammatory and autoimmune...
National Research Grant Canada 2020
The Biocodex Microbiota Foundation calls for Canadian proposals to study the microbiome’s role in health and diseases
August 17, 2020 11:56 ET | Biocodex Canada
MONTREAL, Aug. 17, 2020 (GLOBE NEWSWIRE) -- The Biocodex Microbiota Foundation, an organization founded by Biocodex and dedicated to inspiring scientific projects that explore the microbiome, is...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Launches TruBIOME™ to Create Animal Models with Custom Microbiome Profiles
April 15, 2019 09:00 ET | Taconic Biosciences
RENSSELAER, N.Y., April 15, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces the launch of TruBIOMETM, a first of...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Licenses the Wild Mouse Gut Microbiome from the National Institute of Diabetes and Digestive and Kidney Diseases
April 01, 2019 11:43 ET | Taconic Biosciences
RENSSELAER, N.Y., April 01, 2019 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces it has obtained a license to the Wild...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Expands Microbiome Portfolio
May 04, 2017 15:14 ET | Taconic Biosciences
HUDSON, N.Y., May 04, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free mice,...
Taconic_Logo_Vert_Process_Medium resize.jpg
Taconic Biosciences Expands Microbiome Product and Service Platform
April 26, 2017 11:03 ET | Taconic Biosciences
HUDSON, N.Y., April 26, 2017 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in genetically engineered mouse models and associated services and the only commercial provider of germ-free...